NEW YORK, June 7-Lexicon Genetics has granted a license to its isogenic DNA technology to Millennium Pharmaceuticals, the company said yesterday.
The license, which is nonexclusive, will allow Millennium to use the technology in drug discovery and target validation.
Financial details were not disclosed.
Lexicon, based in The Woodlands, Tx., has developed a range of techniques to improve gene knockout technology.